BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Forward Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 12:59 pm Sale |
2021-12-31 | 13G | Forward Pharma A/S FWPAY |
BIOTECHNOLOGY VALUE FUND L P | 25,176 7.300% |
-10,506![]() (-29.44%) |
Filing |
2021-02-11 5:18 pm Sale |
2020-12-31 | 13G | Forward Pharma A/S FWPAY |
BIOTECHNOLOGY VALUE FUND L P | 35,682 10.700% |
-13,643![]() (-27.66%) |
Filing |